ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,438, issued on Dec. 30, was assigned to US Patent Innovations LLC (Annapolis, Md.).
"System and method for cold plasma therapy with HER-family receptors" was invented by Xiaoqian Cheng (Falls Church, Va.) and Jerome Canady (Lakeland, Fla.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A system and method for using a concomitant effect of cold atmospheric plasma and Trastuzumab to overcome Trastuzumab invalidity or resistance and enhances the outcome of breast cancer therapy in both HER2-positive and negative cancer cells."
The patent was filed on Aug. 22, 2019, under Application No. 16/547,940.
*For further information, including images, charts an...